Bioventus (BVS) Equity Ratio (2020 - 2026)

Bioventus (BVS) has 7 years of Equity Ratio data on file, last reported at 0.29 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 8.24% year-over-year to 0.29; the trailing twelve-month figure through Mar 2026 stood at 0.29 (up 8.24% YoY), and the FY2025 full-year result was 0.33, up 31.08% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.29, down from 0.33 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.5 in Q2 2022 and bottomed at 0.24 in Q3 2025.
• The 5-year median for Equity Ratio is 0.28 (2023), against an average of 0.3.
• The widest annual swing landed in 2022, when Equity Ratio soared 44.81%; it then slumped 45.39% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.3 in 2022, then decreased by 9.2% to 0.27 in 2023, then fell by 6.5% to 0.25 in 2024, then soared by 31.08% to 0.33 in 2025, then slipped by 13.11% to 0.29 in 2026.
• The last three Equity Ratio figures came in at 0.29 (Q1 2026), 0.33 (Q4 2025), and 0.24 (Q3 2025), per Business Quant data.

Peer Comparison